Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices.
Journal: JCO precision oncology
Published: April 22, 2026
Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.
Journal: Journal of the advanced practitioner in oncology
Published: January 13, 2025
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2024
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Journal: Sarcoma
Published: November 18, 2019
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 29, 2016
Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities.
Journal: The British journal of dermatology
Published: March 05, 2015
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 16, 2015
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
Journal: Cancer
Published: September 19, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 04, 2014
An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 26, 2014
Last Updated: 09/26/2026